Fish oil in recent onset rheumatoid arthritis: A randomised, double-blind controlled trial within algorithm-based drug use

Annals of the Rheumatic Diseases

Volumn 74, Issue 1, 2015, Pages 89-95

  Proudman, Susanna M ^a,b   James, Michael J ^a,b   Spargo, Llewellyn D ^a   Metcalf, Robert G ^a   Sullivan, Thomas R ^c   Rischmueller, Maureen ^d   Flabouris, Katerina ^b   Wechalekar, Mihir D ^a   Lee, Anita T ^a   Cleland, Leslie G ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; EPITOPE; FISH OIL; FOLIC ACID; GLUCOCORTICOID; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID; ANTIRHEUMATIC AGENT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; ISOXAZOLE DERIVATIVE;

ADULT; ALLERGIC PNEUMONITIS; AMYLOIDOSIS; ANTIBODY TITER; ARTICLE; BRAIN HEMORRHAGE; CHOLELITHIASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INTOLERANCE; HEALTH ASSESSMENT QUESTIONNAIRE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HERPES ZOSTER; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONONUCLEOSIS; MORNING STIFFNESS; NECK INJURY; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATOID ARTHRITIS; STOMACH ULCER; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; VISUAL ANALOG SCALE; AGED; ARTHRITIS, RHEUMATOID; BLOOD; DRUG COMBINATION; EARLY INTERVENTION; TREATMENT OUTCOME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EARLY MEDICAL INTERVENTION; EICOSAPENTAENOIC ACID; FEMALE; FISH OILS; HUMANS; HYDROXYCHLOROQUINE; ISOXAZOLES; MALE; METHOTREXATE; MIDDLE AGED; REMISSION INDUCTION; SULFASALAZINE; TREATMENT OUTCOME;

EID: 84918837536     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204145     Document Type: Article

References (25)

1. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000;71(Suppl):343S-8S.
2. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007;129:210-23.
3. Fortin PR, Lew RA, Liang MH, et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 1995;48:1379-90.
4. Cleland LG, James MJ, Proudman SM. Fish oil: what the prescriber needs to know. Arthritis Res Ther 2006;8:202.
5. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arthritis Rheum 1990;33:810-20.
6. Kremer JM, Lawrence DA, Petrillo GF, et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Arthritis Rheum 1995;38:1107-14.
7. James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 1997;27:85-97.
8. Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
9. Proudman SM, Keen HI, Stamp LK, et al. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Semin Arthritis Rheum 2007;37:99-111.
10. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 Revised Criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis & Rheumatism 1981;24:1308-15.
12. Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005;23:S93-9.
13. Pincus T, Summey JA, Soraci SA Jr,, et al Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.
14. James MJ, Proudman SM, Cleland LG. Fish oil and rheumatoid arthritis: Past, present and future. Proc Nutr Soc 2010;69:316-23.
15. Moreland LW, O'Dell JR, Paulus HE, et al. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of early aggressive rheumatoid arthritis trial. Arthritis Rheum 2012;64:2824-35.
16. Proudman SM, Cleland LG, James MJ. Dietary omega-3 fats for treatment of inflammatory joint disease: efficacy and utility. Rheum Dis Clin North Am 2008;34:469-79.
17. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-61.
18. John H, Kitas G, Toms T, et al. Cardiovascular co-morbidity in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2009;23:71-82.
19. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11.
20. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57.
21. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Acta Med Scand 1980;208:401-6.
22. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979;2:433-5.
23. Harris WS. Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am J Cardiol 2007;99:44C-6C.
24. Rothwell PM. Factors that can affect the external validity of randomised controlled trials. PLoS Clin Trials 2006;1:e9.
25. Pincus T, Sokka T. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa? Ann Rheum Dis 2004;63(Suppl 2):ii32-9.